Successful Treatment of a Miliary Metastatic NSCLC Patient With Activating EGFR Exon 20 Insertion Mutation with Response to Poziotinib

被引：6
|
作者：
Yang, Juyin [1 ]
Yang, Jian [2 ]
Ban, Shao [3 ]
Li, Xinmin [2 ]
Chen, Xingde [4 ]
Yang, Jihua [4 ]
Qian, Jun [2 ]
机构：
[1] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Pharm, Dehong, Yunnan, Peoples R China
[2] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Cardiothorac Surg, 13 Yonghan St, Dehong 678400, Yunnan, Peoples R China
[3] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Cardiovasc Med, Dehong, Yunnan, Peoples R China
[4] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Pathol, Dehong, Yunnan, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 09期
关键词：
D O I：
10.1016/j.jtho.2019.04.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E198 / E200
页数：3
相关论文
共 50 条
  • [1] Poziotinib in NSCLC harbouring EGFR or HER2 exon 20 insertion mutation
    Prelaj, A.
    Bottiglieri, A.
    Galli, E.
    Lo Russo, G.
    Ferrara, R.
    Galli, G.
    De Toma, A.
    Brambilla, M.
    Occhipinti, M.
    Manglaviti, S.
    Beninato, T.
    Zattarin, E.
    Apollonio, G.
    Ganzinelli, M.
    Gallucci, R.
    Di Mauro, R. M.
    de Braud, F.
    Torri, V.
    Garassino, M. C. C.
    Proto, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S976 - S977
  • [2] Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
    Prelaj, Arsela
    Bottiglieri, Achille
    Bhat, Gajanan
    Washington, Rocky
    Calareso, Giuseppina
    Greco, Gabriella Francesca
    Ferrara, Roberto
    Brambilla, Marta
    De Toma, Alessandro
    Occhipinti, Mario
    Manglaviti, Sara
    Soro, Alberto
    Ganzinelli, Monica
    Lo Russo, Giuseppe
    Proto, Claudia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use
    Pandey, Apurva
    Brufsky, Adam M.
    CLINICAL BREAST CANCER, 2019, 19 (01) : E7 - E11
  • [4] Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
    Prelaj, Arsela
    Bottiglieri, Achille
    Proto, Claudia
    Lo Russo, Giuseppe
    Signorelli, Diego
    Ferrara, Roberto
    Galli, Giulia
    De Toma, Alessandro
    Viscardi, Giuseppe
    Brambilla, Marta
    Lobefaro, Riccardo
    Nichetti, Federico
    Manglaviti, Sara
    Occhipinti, Mario
    Labianca, Alice
    Ganzinelli, Monica
    Gallucci, Rosaria
    Zilembo, Nicoletta
    Greco, Gabriella Francesca
    Torri, Valter
    de Braud, Filippo
    Garassino, Marina C.
    EUROPEAN JOURNAL OF CANCER, 2021, 149 : 235 - 248
  • [5] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
    Lv, D.
    Lin, L.
    Wu, X.
    Yan, S.
    Ge, H.
    Yan, Z.
    Wang, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S634 - S634
  • [6] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
    Lin, Ling
    Wu, Xiaomai
    Yan, Shuangquan
    Zhu, Yefei
    Yan, Zhengqing
    Lv, Dongqing
    Ge, Hongfei
    ONCOTARGETS AND THERAPY, 2020, 13 : 9753 - 9757
  • [7] Clinical Response to Osimertinib in a Patient with Metastatic NSCLC Harboring EGFR A763_Y764insFQEA Exon 20 Insertion Mutation: A Case Report
    Montenegro, G. Bravo
    Kim, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S575 - S576
  • [8] CNS activity of poziotinib in NSCLC with exon 20 insertion mutations.
    Le, Xiuning
    Garassino, Marina Chiara
    Cornelissen, Robin
    Socinski, Mark A.
    Tchekmedyian, Nishan
    Molina, Julian R.
    Baik, Christina S.
    Leu, Sharon
    Dreiling, Lyndah
    Lebel, Francois M.
    Clarke, Jeffrey Melson
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC
    Ninomiya, Kiichiro
    ANNALS OF ONCOLOGY, 2022, 33 : S444 - S444
  • [10] Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation
    Zoechbauer-Mueller, Sabine
    Kaserer, Bettina
    Prosch, Helmut
    Cseh, Agnieszka
    Solca, Flavio
    Bauer, Markus Johann
    Muellauer, Leonhard
    FRONTIERS IN ONCOLOGY, 2021, 10
12345